Search results
Results from the WOW.Com Content Network
Approved by the FDA in 2019 for treatment of epilepsy in adults, cenobamate is primarily used to treat patients with focal onset seizures. The mechanism of action of this drug is unclear, but is likely related to the inactivation of Na Channels and action as a GABA modulator. The dosing range for this drug is anywhere from 100-400 mg with a ...
Diazepam, sold under the brand name Valium among others, is a medicine of the benzodiazepine family that acts as an anxiolytic. [15] It is used to treat a range of conditions, including anxiety, seizures, alcohol withdrawal syndrome, muscle spasms, insomnia, and restless legs syndrome. [15]
Local epilepsy advocates have developed emergency medical cards with a step-by-step guide for people who encounter someone experiencing a seizure. People with epilepsy can get seizures at any time ...
Medications that alter immune function, such as intravenous immunoglobulins, may reduce the frequency of seizures when including in normal care as an add-on therapy; however, further research is required to determine whether these medications are very well tolerated in children and in adults with epilepsy. [243]
Simple febrile seizures involve an otherwise healthy child who has at most one tonic-clonic seizure lasting less than 15 minutes in a 24-hour period. [1] Complex febrile seizures have focal symptoms, last longer than 15 minutes, or occur more than once within 24 hours. [5] About 80% are classified as simple febrile seizures. [6]
It is recommended by the World Health Organization (WHO) for the treatment of certain types of epilepsy in developing countries. [8] In the developed world, it is commonly used to treat seizures in young children, [9] while other medications are generally used in older children and adults. [10] It is also used for veterinary purposes. [11]
Status epilepticus (SE), or status seizure, is a medical condition with abnormally prolonged seizures.It can have long-term consequences, [3] manifesting as a single seizure lasting more than a defined time (time point 1), or 2 or more seizures over the same period without the person returning to normal between them.
Therefore, almost all new epilepsy drugs are initially approved only as adjunctive (add-on) therapies. Patients whose epilepsy is uncontrolled by their medication (i.e., it is refractory to treatment) are selected to see if supplementing the medication with the new drug leads to an improvement in seizure control.